Crossmark

New Developments in the Treatment of X-Linked Hypophosphataemia: Implications for Clinical Management

Published Online: 2020-01-22

Published Print: 2020-04

Authors

Saraff, Vrinda

Nadar, Ruchi

Högler, Wolfgang http://orcid.org/0000-0003-4328-6304
License Information

Text and Data Mining valid from 2020-01-22

Version of Record valid from 2020-01-22
More Information

Article History

First Online: 22 January 2020

Compliance with Ethical Standards

:

: VS and WH were investigators for clinical studies sponsored by Ultragenyx and received honoraria and travel support from Kyowa Kirin for participation on advisory boards. WH received research grant support by Kyowa Kirin. RN has no disclosures.

Document is current